Prevention of Restenosis Following Revascularization
NCT00518284 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2012-03-13
Summary
The purpose of this study is to investigate the prevention of Restenosis following Revascularization of the superficial Femoral Artery (SFA)
Conditions
- Vascular Disease, Peripheral
Interventions
- DRUG
-
Nanoparticle Paclitaxel
Nanoparticle albumin-bound paclitaxel, 45 mg/m\^2.
Sponsors & Collaborators
-
Celgene Corporation
lead INDUSTRY
Principal Investigators
-
José Iglesias, MD · Celgene Corporation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2009-08-31
- Completion
- 2009-09-30
Countries
- United States
Study Locations
More Related Trials
-
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
NCT05498740 ·Status: UNKNOWN ·Phase: NA
-
Paclitaxel Eluting Balloon for SFA In-stent Restenosis
NCT01616888 ·Status: UNKNOWN ·Phase: NA
-
Platelet Rich Plasma Study in Lower Extremity Bypass Surgery
NCT00517452 ·Status: COMPLETED
-
Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2)
NCT02040454 ·Status: WITHDRAWN ·Phase: PHASE2
-
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
NCT01083030 ·Status: COMPLETED ·Phase: PHASE3
-
Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions
NCT01298947 ·Status: UNKNOWN ·Phase: NA
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884 ·Status: COMPLETED ·Phase: NA
-
DEFINITIVE AR Two Year Follow-up Extension Study
NCT02363894 ·Status: COMPLETED
-
3 Month PHI PAD PoM Study
NCT02135848 ·Status: COMPLETED ·Phase: PHASE2
-
Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
NCT00504088 ·Status: TERMINATED ·Phase: PHASE4
-
A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia
NCT02974179 ·Status: COMPLETED
-
Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)
NCT04496544 ·Status: COMPLETED
-
Tack Optimized Balloon Angioplasty Post-Market Study
NCT05361967 ·Status: TERMINATED
-
To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease
NCT05662618 ·Status: UNKNOWN ·Phase: NA
-
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
NCT05007925 ·Status: COMPLETED ·Phase: NA
-
The SIR-POBA Bypass Trial
NCT06056193 ·Status: WITHDRAWN ·Phase: NA
-
Diamondback in Peripheral Vascular Disease
NCT03455374 ·Status: TERMINATED ·Phase: NA
-
Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries
NCT02953496 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.
NCT05497440 ·Status: WITHDRAWN ·Phase: NA
-
Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula
NCT06029569 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Paclitaxel-Coated Balloon for the Treatment of AVF
NCT05088083 ·Status: UNKNOWN ·Phase: NA
-
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
NCT05450042 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II
NCT05454995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Zilver PTX Post-Market Study in Japan
NCT02254837 ·Status: COMPLETED ·Phase: NA
-
Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease
NCT01007578 ·Status: COMPLETED ·Phase: PHASE1